Classical Complement Pathway Inhibitor [EPC]

Classical Complement Pathway Inhibitor [EPC] was reported 321 times

Drugs of the Classical Complement Pathway Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 B-CELL MALIGNANCY 1 0.5000
1 CELLULITIS PASTEURELLA 1 0.2500
2 WHITE BLOOD CELL AGGLUTINATION PRESENT 1 0.0833
3 LIGHT CHAIN ANALYSIS 1 0.0417
4 RED BLOOD CELL AGGLUTINATION 1 0.0263
5 DEVICE MATERIAL OPACIFICATION 1 0.0222
6 TRAUMATIC SUBARACHNOID HAEMORRHAGE 1 0.0156
7 BURSA INJURY 1 0.0154
8 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 4 0.0110
9 COLD TYPE HAEMOLYTIC ANAEMIA 2 0.0085
10 WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0071
11 HIGH-GRADE B-CELL LYMPHOMA 1 0.0053
12 HEPATITIS VIRAL 4 0.0050
13 SCINTILLATING SCOTOMA 1 0.0045
14 AUTOANTIBODY POSITIVE 1 0.0036
15 INFECTION REACTIVATION 4 0.0035
16 BLOOD IMMUNOGLOBULIN M INCREASED 2 0.0033
17 TRANSFUSION-RELATED ACUTE LUNG INJURY 1 0.0032
18 SICKLE CELL ANAEMIA 2 0.0031
19 LYMPHOMA TRANSFORMATION 1 0.0028
20 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 1 0.0027
21 BREAKTHROUGH HAEMOLYSIS 1 0.0025
22 CAT SCRATCH DISEASE 1 0.0025
23 HAPTOGLOBIN DECREASED 2 0.0025
24 PERIPHERAL CIRCULATORY FAILURE 1 0.0024
25 TRANSFERRIN SATURATION DECREASED 1 0.0023
26 HAEMOLYSIS 16 0.0021
27 URINARY TRACT PAIN 1 0.0020
28 HAEMOGLOBINURIA 2 0.0018
29 SERONEGATIVE ARTHRITIS 2 0.0017
30 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0017
31 PNEUMOCOCCAL SEPSIS 1 0.0015
32 LIVEDO RETICULARIS 3 0.0014
33 DISSOCIATIVE DISORDER 1 0.0014
34 DIZZINESS EXERTIONAL 1 0.0013
35 ENDOCARDITIS BACTERIAL 1 0.0013
36 VASCULAR ACCESS COMPLICATION 1 0.0012
37 CAMPYLOBACTER INFECTION 1 0.0012
38 FOLLICULAR LYMPHOMA 1 0.0011
39 CANDIDA SEPSIS 1 0.0011
40 HEPATIC NECROSIS 4 0.0011
41 ANIMAL SCRATCH 1 0.0010
42 HAEMOPHILUS INFECTION 1 0.0010
43 BLAST CELL COUNT INCREASED 1 0.0010
44 STRESS URINARY INCONTINENCE 1 0.0009
45 LIMB MASS 2 0.0009
46 PULMONARY SARCOIDOSIS 1 0.0009
47 BILE DUCT CANCER 1 0.0008
48 INFECTED CYST 1 0.0008
49 BLOOD IMMUNOGLOBULIN G INCREASED 1 0.0008
50 URINARY TRACT INFECTION BACTERIAL 2 0.0008
51 HAEMOGLOBIN ABNORMAL 5 0.0008
52 GENITAL RASH 1 0.0007
53 CYANOSIS 11 0.0007
54 MARASMUS 1 0.0007
55 PNEUMONIA PSEUDOMONAL 1 0.0007
56 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
57 BLADDER PAIN 2 0.0006
58 METABOLIC SYNDROME 1 0.0006
59 OTITIS MEDIA 2 0.0006
60 B-CELL LYMPHOMA 2 0.0006
61 RHEUMATIC DISORDER 1 0.0005
62 VASCULAR OCCLUSION 1 0.0005
63 LYMPHOMA 7 0.0005
64 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
65 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
66 HAEMORRHAGE URINARY TRACT 1 0.0004
67 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
68 ANIMAL BITE 1 0.0004
69 WHITE BLOOD CELL DISORDER 1 0.0004
70 ALCOHOL POISONING 1 0.0004
71 COMPRESSION FRACTURE 2 0.0004
72 RHINALGIA 1 0.0004
73 ACUTE PULMONARY OEDEMA 2 0.0004
74 NECK INJURY 1 0.0003
75 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
76 SYMPTOM RECURRENCE 2 0.0003
77 CENTRAL VENOUS CATHETERISATION 1 0.0003
78 NON-CARDIAC CHEST PAIN 1 0.0003
79 PRODUCT PREPARATION ISSUE 2 0.0003
80 DEAFNESS NEUROSENSORY 1 0.0003
81 ACUTE HEPATIC FAILURE 4 0.0003
82 HEPATIC FIBROSIS 1 0.0003
83 APLASIA PURE RED CELL 1 0.0003
84 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
85 GALLBLADDER OPERATION 1 0.0002
86 SPINAL STENOSIS 1 0.0002
87 OCULAR ICTERUS 1 0.0002
88 HAEMOGLOBIN DECREASED 23 0.0002
89 OROPHARYNGEAL DISCOMFORT 2 0.0002
90 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
91 HYPOVOLAEMIC SHOCK 1 0.0002
92 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
93 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
94 SUBARACHNOID HAEMORRHAGE 2 0.0002
95 BLOOD LACTIC ACID INCREASED 1 0.0002
96 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
97 HYPERTENSIVE CRISIS 2 0.0002
98 STREPTOCOCCAL INFECTION 1 0.0002
99 NECROSIS 1 0.0002
100 BLOOD URIC ACID INCREASED 1 0.0002
101 PROTHROMBIN TIME PROLONGED 1 0.0002
102 LEUKOCYTOSIS 3 0.0002
103 PLATELET COUNT ABNORMAL 1 0.0002
104 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
105 INGUINAL HERNIA 1 0.0002
106 INFUSION SITE EXTRAVASATION 1 0.0002
107 SARS-COV-2 TEST POSITIVE 2 0.0002
108 CHOLECYSTITIS CHRONIC 1 0.0001
109 PRODUCT PREPARATION ERROR 3 0.0001
110 HAEMATURIA 5 0.0001
111 PERIPHERAL COLDNESS 2 0.0001
112 APHONIA 2 0.0001
113 IMMUNODEFICIENCY 2 0.0001
114 ATRIOVENTRICULAR BLOCK 1 0.0001
115 PELVIC FRACTURE 1 0.0001
116 ACUTE MYELOID LEUKAEMIA 2 0.0001
117 HAEMORRHAGIC STROKE 1 0.0001
118 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
119 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
120 RHINORRHOEA 8 0.0001
121 MUSCLE DISORDER 1 0.0001
122 CEREBRAL INFARCTION 3 0.0001
123 EMBOLISM 1 0.0001
124 CARDIAC OPERATION 1 0.0001
125 BLOOD MAGNESIUM DECREASED 1 0.0001
126 PYELONEPHRITIS 1 0.0001
127 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
128 HAEMOLYTIC ANAEMIA 1 0.0001
129 GASTROINTESTINAL INFECTION 1 0.0001
130 VENTRICULAR EXTRASYSTOLES 1 0.0001
131 EYE DISCHARGE 1 0.0001
132 TRANSFUSION 1 0.0001
133 SUDDEN DEATH 1 0.0001
134 MICTURITION URGENCY 1 0.0001
135 BLOOD IRON DECREASED 1 0.0001
136 BACTERAEMIA 1 0.0001
137 CHOLECYSTITIS 1 0.0001
138 ADRENAL INSUFFICIENCY 1 0.0001
139 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
140 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
141 BEDRIDDEN 1 0.0001
142 TOOTH INFECTION 1 0.0001
143 INFUSION RELATED REACTION 5 0.0001
144 QUALITY OF LIFE DECREASED 1 0.0001
145 JAUNDICE 2 0.0001
146 BLOOD BILIRUBIN INCREASED 2 0.0001
147 RESPIRATORY DISTRESS 2 0.0001
148 DIVERTICULITIS 2 0.0001
149 FEELING COLD 2 0.0001
150 SINUS TACHYCARDIA 1 0.0001
151 PARALYSIS 1 0.0001
152 IMPAIRED QUALITY OF LIFE 1 0.0001
153 MENTAL DISORDER 3 0.0001
154 COVID-19 12 0.0001
155 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
156 HYPOAESTHESIA ORAL 1 0.0001
157 RENAL DISORDER 3 0.0001
158 BLOOD CHOLESTEROL INCREASED 3 0.0001
159 MENINGIOMA 1 0.0001
160 CYSTITIS 2 0.0001
161 CYTOMEGALOVIRUS INFECTION 1 0.0001
162 VIRAL INFECTION 2 0.0001
163 PERICARDITIS 1 0.0001
164 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
165 MUSCULOSKELETAL DISCOMFORT 1 0.0001
166 HYPOXIA 2 0.0001
167 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
168 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
169 PELVIC PAIN 1 0.0001
170 BONE DISORDER 1 0.0001
171 ARTHROPATHY 3 0.0001
172 SEPSIS 6 0.0001
173 HEPATIC STEATOSIS 1 0.0001
174 COLITIS 2 0.0001
175 BLOOD URINE PRESENT 1 0.0001
176 HAEMATOCRIT DECREASED 1 0.0001
177 PRESCRIBED UNDERDOSE 1 0.0001
178 CONDITION AGGRAVATED 15 0.0000
179 FEEDING DISORDER 1 0.0000
180 PLEURAL EFFUSION 3 0.0000
181 TASTE DISORDER 1 0.0000
182 NEUTROPHIL COUNT DECREASED 2 0.0000
183 ARTHRALGIA 20 0.0000
184 MOUTH ULCERATION 1 0.0000
185 EATING DISORDER 1 0.0000
186 POOR QUALITY SLEEP 1 0.0000
187 PRODUCT PRESCRIBING ISSUE 1 0.0000
188 PERIPHERAL SWELLING 7 0.0000
189 NEOPLASM MALIGNANT 3 0.0000
190 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
191 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
192 OFF LABEL USE 39 0.0000
193 THERAPY NON-RESPONDER 2 0.0000
194 CHROMATURIA 1 0.0000
195 SKIN DISCOLOURATION 2 0.0000
196 SLEEP DISORDER 3 0.0000
197 DISEASE PROGRESSION 5 0.0000
198 ARRHYTHMIA 2 0.0000
199 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
200 PULMONARY EMBOLISM 4 0.0000
201 PRODUCT PRESCRIBING ERROR 1 0.0000
202 ANAEMIA 8 0.0000
203 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
204 LOCALISED INFECTION 1 0.0000
205 INTERSTITIAL LUNG DISEASE 2 0.0000
206 URINARY TRACT INFECTION 7 0.0000
207 OEDEMA PERIPHERAL 5 0.0000
208 ENCEPHALOPATHY 1 0.0000
209 GASTRIC CANCER 1 0.0000
210 RESPIRATORY TRACT INFECTION 1 0.0000
211 DEAFNESS 1 0.0000
212 EAR INFECTION 1 0.0000
213 CARDIAC FAILURE 3 0.0000
214 OEDEMA 2 0.0000
215 LIMB INJURY 1 0.0000
216 SKIN LESION 1 0.0000
217 DEMENTIA 1 0.0000
218 HYPONATRAEMIA 2 0.0000
219 INTENTIONAL DOSE OMISSION 1 0.0000
220 HERPES ZOSTER 2 0.0000
221 SURGERY 2 0.0000
222 NASAL CONGESTION 2 0.0000
223 ACUTE MYOCARDIAL INFARCTION 1 0.0000
224 OESOPHAGEAL CARCINOMA 1 0.0000
225 APHASIA 1 0.0000
226 STOMATITIS 2 0.0000
227 LIMB DISCOMFORT 1 0.0000
228 FEMUR FRACTURE 1 0.0000
229 DRUG-INDUCED LIVER INJURY 1 0.0000
230 WEIGHT INCREASED 7 0.0000
231 CHOLELITHIASIS 1 0.0000
232 STAPHYLOCOCCAL INFECTION 1 0.0000
233 FEBRILE NEUTROPENIA 2 0.0000
234 URINARY RETENTION 1 0.0000
235 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
236 ILLNESS 3 0.0000
237 LYMPHADENOPATHY 1 0.0000
238 CEREBRAL HAEMORRHAGE 1 0.0000
239 RESPIRATORY FAILURE 2 0.0000
240 NASOPHARYNGITIS 5 0.0000
241 BRONCHITIS 2 0.0000
242 HEPATIC FUNCTION ABNORMAL 1 0.0000
243 DYSPNOEA EXERTIONAL 1 0.0000
244 BLOOD PRESSURE INCREASED 4 0.0000
245 PALPITATIONS 3 0.0000
246 CHILLS 3 0.0000
247 ARTHRITIS 2 0.0000
248 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
249 CARDIAC FAILURE CONGESTIVE 2 0.0000
250 OSTEOPOROSIS 1 0.0000
251 CARDIAC ARREST 2 0.0000
252 CARDIO-RESPIRATORY ARREST 1 0.0000
253 RENAL IMPAIRMENT 2 0.0000
254 HYPERTENSION 5 0.0000
255 HYPOACUSIS 1 0.0000
256 PYREXIA 8 0.0000
257 FATIGUE 18 0.0000
258 SEPTIC SHOCK 1 0.0000
259 ANGIOEDEMA 1 0.0000
260 TACHYCARDIA 2 0.0000
261 NEUTROPENIA 3 0.0000
262 VISION BLURRED 3 0.0000
263 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
264 PNEUMONIA 7 0.0000
265 RENAL CANCER 1 0.0000
266 HEADACHE 13 0.0000
267 INFECTION 3 0.0000
268 ATRIAL FIBRILLATION 2 0.0000
269 HYPOAESTHESIA 3 0.0000
270 LEUKOPENIA 1 0.0000
271 CELLULITIS 1 0.0000
272 CHEST DISCOMFORT 2 0.0000
273 THERAPY CESSATION 1 0.0000
274 MUSCULOSKELETAL PAIN 1 0.0000
275 SPEECH DISORDER 1 0.0000
276 DEATH 16 0.0000
277 DISTURBANCE IN ATTENTION 1 0.0000
278 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
279 TREATMENT NONCOMPLIANCE 1 0.0000
280 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
281 MEDICATION ERROR 1 0.0000
282 INFLUENZA 2 0.0000
283 PANCYTOPENIA 1 0.0000
284 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
285 DECREASED APPETITE 4 0.0000
286 BACK PAIN 4 0.0000
287 BONE PAIN 1 0.0000
288 BLADDER CANCER 1 0.0000
289 CATARACT 1 0.0000
290 VERTIGO 1 0.0000
291 PAIN 10 0.0000
292 CHEST PAIN 3 0.0000
293 DYSPNOEA 9 0.0000
294 LOSS OF CONSCIOUSNESS 2 0.0000
295 AMNESIA 1 0.0000
296 MEMORY IMPAIRMENT 2 0.0000
297 COUGH 4 0.0000
298 NAUSEA 11 0.0000
299 HOT FLUSH 1 0.0000
300 INJECTION SITE SWELLING 1 0.0000
301 PARAESTHESIA 2 0.0000
302 INJECTION SITE BRUISING 1 0.0000
303 ABDOMINAL DISCOMFORT 2 0.0000
304 BALANCE DISORDER 1 0.0000
305 RASH 5 0.0000
306 MYOCARDIAL INFARCTION 2 0.0000
307 NO ADVERSE EVENT 2 0.0000
308 OROPHARYNGEAL PAIN 1 0.0000
309 WEIGHT DECREASED 3 0.0000
310 CARDIAC DISORDER 1 0.0000
311 ASTHENIA 4 0.0000
312 PRURITUS 4 0.0000
313 ALOPECIA 2 0.0000
314 PAIN IN EXTREMITY 3 0.0000
315 DYSPEPSIA 1 0.0000
316 DIZZINESS 5 0.0000
317 SYNCOPE 1 0.0000
318 HYPOTENSION 2 0.0000
319 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
320 DRUG INEFFECTIVE 13 0.0000
321 FLUSHING 1 0.0000
322 SINUSITIS 1 0.0000
323 HAEMORRHAGE 1 0.0000
324 DIARRHOEA 6 0.0000
325 FALL 3 0.0000
326 THROMBOCYTOPENIA 1 0.0000
327 MUSCULAR WEAKNESS 1 0.0000
328 ABDOMINAL PAIN 2 0.0000
329 VOMITING 4 0.0000
330 JOINT SWELLING 1 0.0000
331 EMOTIONAL DISTRESS 1 0.0000
332 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
333 RENAL FAILURE 1 0.0000
334 ACUTE KIDNEY INJURY 1 0.0000
335 CONFUSIONAL STATE 1 0.0000
336 TREMOR 1 0.0000
337 CEREBROVASCULAR ACCIDENT 1 0.0000
338 MYALGIA 1 0.0000
339 MUSCLE SPASMS 1 0.0000
340 HYPERSENSITIVITY 1 0.0000
341 ERYTHEMA 1 0.0000
342 ABDOMINAL PAIN UPPER 1 0.0000
343 OVERDOSE 1 0.0000
344 MALAISE 2 0.0000
345 FEELING ABNORMAL 1 0.0000
346 PRODUCT DOSE OMISSION ISSUE 1 0.0000
347 INJECTION SITE PAIN 1 0.0000